23 Feb SCM Lifescience

Posted at 19:35h in by brady

BG Rhee, Ph.D., President and CEO

Seoul, Korea

(KOSDAQ: 2908060)

Virtual Presentation

SCM Lifescience is developing allogeneic high purity clonal mesenchymal stem cells for immune related diseases. Three projects that are currently in the Phase II clinical stage deal with moderate to severe atopic dermatitis, chronic GvHD, and moderate to severe acute pancreatitis. SCM is looking for local partners for co-development of these projects in the U.S., EU, and Asia.

www.scmlifescience.com

About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 11-13, 2022
Carlsbad, CA

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions